Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Refractory Germ”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00861107
What this trial is testing

In-Situ Therapeutic Cancer Vaccine for Metastatic Cancer Combining AlloStim With Tumor Cryoablation

Who this might be right for
Metastatic Cancer
Mirror Biologics, Inc. 50
Testing effectiveness (Phase 2)WithdrawnNCT02689336
What this trial is testing

Erlotinib in Combination With Temozolomide in Treating Relapsed/Recurrent/Refractory Pediatric Solid Tumors

Who this might be right for
GliomaRhabdomyosarcomaOsteosarcoma+5 more
Washington University School of Medicine
Testing effectiveness (Phase 2)Ended earlyNCT05420636
What this trial is testing

Iadademstat in Combination With Paclitaxel in Relapsed/Refractory SCLC and Extrapulmonary High Grade NET

Who this might be right for
Small-cell Lung CancerNeuroendocrine Carcinoma
Fox Chase Cancer Center 20
Testing effectiveness (Phase 2)WithdrawnNCT04791228
What this trial is testing

A Pilot Study of Thermodox and MR-HIFU for Treatment of Relapsed Solid Tumors

Who this might be right for
Solid TumorsSoft Tissue SarcomaEwing Sarcoma+6 more
Children's National Research Institute
Testing effectiveness (Phase 2)Study completedNCT00002814
What this trial is testing

Combination Chemotherapy for Patients With Brain Cancer

Who this might be right for
Brain and Central Nervous System Tumors
Dartmouth-Hitchcock Medical Center 20
Early research (Phase 1)Study completedNCT00107458
What this trial is testing

Valproic Acid in Treating Young Patients With Recurrent or Refractory Solid Tumors or CNS Tumors

Who this might be right for
Brain and Central Nervous System TumorsUnspecified Childhood Solid Tumor, Protocol Specific
Children's Oncology Group 26
Early research (Phase 1)Ended earlyNCT05429502
What this trial is testing

Study of Efficacy and Safety of Ribociclib (LEE011) in Combination With Topotecan and Temozolomide (TOTEM) in Pediatric Patients With Relapsed or Refractory Neuroblastoma and Other Solid Tumors

Who this might be right for
Neuroblastoma
Novartis Pharmaceuticals 12
Testing effectiveness (Phase 2)UnknownNCT00772694
What this trial is testing

Sorafenib Monotherapy in Inoperable/Recurrent Germ Cell Carcinoma Refractory to Chemotherapy

Who this might be right for
Testicular Cancer
Fondation Wygrajmy Zdrowie 20
Testing effectiveness (Phase 2)UnknownNCT02743429
What this trial is testing

Phase II Study of Monoclonal Antibody ch14.18/CHO Continuous Infusion in Patients With Primary Refractory or Relapsed Neuroblastoma

Who this might be right for
Neuroblastoma
University Medicine Greifswald 40
Early research (Phase 1)Looking for participantsNCT02508038
What this trial is testing

Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic LeukemiaHodgkin Lymphoma+8 more
University of Wisconsin, Madison 22
Testing effectiveness (Phase 2)Study completedNCT01631552
What this trial is testing

Study of Sacituzumab Govitecan-hziy (IMMU-132) in Adults With Epithelial Cancer

Who this might be right for
Gastric AdenocarcinomaEsophageal CancerHepatocellular Carcinoma+13 more
Gilead Sciences 515
Early research (Phase 1)Study completedNCT00206388
What this trial is testing

Zoledronic Acid (ZOMETA) With Cyclophosphamide With Neuroblastoma and Cortical Bone Involvement

Who this might be right for
NEUROBLASTOMA
Baylor College of Medicine 21
Not applicableStudy completedNCT01850888
What this trial is testing

MIBG for Refractory Neuroblastoma and Pheochromocytoma

Who this might be right for
Relapsed NeuroblastomaMetastatic Pheochromocytoma
Masonic Cancer Center, University of Minnesota 15
Testing effectiveness (Phase 2)Study completedNCT00611962
What this trial is testing

Phase II Study of Oxaliplatine-Paclitaxel in Patients With Metastatic Germ Cell Tumor Refractory to Cisplatin

Who this might be right for
Neoplasms, Germ Cell and Embryonal
Sanofi 27
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07261241
What this trial is testing

NANT 2021-02: Randomized MIBG With Vorinostat/Dinutuximab/Vorinostat + Dinutuximab

Who this might be right for
Neuroblastoma
New Approaches to Neuroblastoma Therapy Consortium 118
Early research (Phase 1)UnknownNCT05068453
What this trial is testing

Study of Oncolytic Virus in Combination With HX-008 and Radiotherapy in Melanoma Patients With Liver Metastasis

Who this might be right for
Melanoma Stage IV
Peking University Cancer Hospital & Institute 15
Early research (Phase 1)Ended earlyNCT00689065
What this trial is testing

Safety Study of CALAA-01 to Treat Solid Tumor Cancers

Who this might be right for
CancerSolid Tumor
Calando Pharmaceuticals 24
Not applicableActive Not RecruitingNCT04970134
What this trial is testing

Spanish Study for Molecular Characterization of Thyroid Carcinoma

Who this might be right for
Differentiated Thyroid CarcinomaMedullary Thyroid Carcinoma
Grupo Español de Tratamiento de Tumores de Cabeza y Cuello 150
Testing effectiveness (Phase 2)UnknownNCT03916757
What this trial is testing

V-Boost Immunotherapy in Glioblastoma Multiforme Brain Cancer

Who this might be right for
Glioblastoma MultiformeGlioma of Brain
Immunitor LLC 20
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06948994
What this trial is testing

A Clinical Trial on Autologous NK Cells Combined With GD2 Monoclonal Antibody in the Treatment of Children With Newly Diagnosed High-risk or Relapsed/Refractory Neuroblastoma

Who this might be right for
NeuroblastomaGD2 AntibodyAutologous NK Cell
Guangzhou Women and Children's Medical Center 15
Next Page